X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13276) 13276
Magazine Article (11) 11
Book / eBook (10) 10
Conference Proceeding (10) 10
Dissertation (3) 3
Book Chapter (2) 2
Web Resource (2) 2
Book Review (1) 1
Newsletter (1) 1
Publication (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12607) 12607
hepacivirus - immunology (6750) 6750
female (6403) 6403
male (6392) 6392
adult (5273) 5273
hepacivirus - genetics (5269) 5269
middle aged (5185) 5185
hepatitis c virus (4762) 4762
hepatitis c (4061) 4061
immunology (2967) 2967
hepatitis c - immunology (2942) 2942
infection (2906) 2906
virology (2758) 2758
hepatitis (2739) 2739
aged (2638) 2638
infectious diseases (2626) 2626
hepatitis c - virology (2459) 2459
genotype (2344) 2344
gastroenterology & hepatology (2313) 2313
hepacivirus - isolation & purification (2127) 2127
viruses (2068) 2068
infections (2034) 2034
hepatitis c - epidemiology (1956) 1956
antiviral agents - therapeutic use (1943) 1943
health aspects (1908) 1908
prevalence (1886) 1886
hepacivirus (1868) 1868
microbiology (1812) 1812
interferon (1751) 1751
virus diseases (1748) 1748
hcv (1676) 1676
risk factors (1630) 1630
animals (1616) 1616
hepatitis c, chronic - drug therapy (1566) 1566
hepatitis c, chronic - virology (1557) 1557
rna, viral - blood (1557) 1557
liver (1554) 1554
hepacivirus - physiology (1540) 1540
rna (1515) 1515
hepatitis c antibodies - blood (1446) 1446
hepatitis c - complications (1438) 1438
hepatitis c - diagnosis (1425) 1425
hepacivirus - drug effects (1401) 1401
adolescent (1398) 1398
hepatitis c, chronic - immunology (1329) 1329
research article (1283) 1283
treatment outcome (1262) 1262
hiv (1236) 1236
digestive system diseases (1164) 1164
molecular sequence data (1162) 1162
antibodies (1154) 1154
interferon-alpha - therapeutic use (1147) 1147
viral load (1136) 1136
medicine (1128) 1128
hepatitis c - drug therapy (1119) 1119
enzyme-linked immunosorbent assay (1089) 1089
polymerase chain reaction (1088) 1088
ribavirin (1076) 1076
research (1047) 1047
multidisciplinary sciences (1044) 1044
hepatitis c - transmission (1011) 1011
analysis (1009) 1009
therapy (976) 976
ribavirin - therapeutic use (971) 971
hepatitis-c virus (966) 966
genotypes (949) 949
rna, viral - analysis (949) 949
hepatitis antibodies - blood (937) 937
science (936) 936
hepatitis c antibodies (925) 925
non-a (909) 909
proteins (882) 882
liver diseases (879) 879
drug therapy, combination (875) 875
hepacivirus - pathogenicity (872) 872
retrospective studies (870) 870
virus-infection (839) 839
young adult (832) 832
replication (822) 822
transplantation (820) 820
genetic aspects (800) 800
hepatitis c - blood (793) 793
hiv infections - complications (775) 775
care and treatment (771) 771
epidemiology (766) 766
mice (757) 757
gastroenterology and hepatology (755) 755
rna, viral - genetics (749) 749
cell line (747) 747
expression (744) 744
antiviral agents (734) 734
hepatitis antibodies - analysis (727) 727
amino acid sequence (726) 726
base sequence (691) 691
patients (687) 687
cirrhosis (683) 683
time factors (683) 683
hepatitis c, chronic - complications (680) 680
hepatocellular-carcinoma (665) 665
recombinant proteins (663) 663
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12742) 12742
Japanese (230) 230
Spanish (156) 156
Chinese (149) 149
French (121) 121
Russian (116) 116
Portuguese (99) 99
German (56) 56
Italian (45) 45
Polish (32) 32
Hungarian (23) 23
Turkish (12) 12
Czech (9) 9
Norwegian (7) 7
Romanian (6) 6
Swedish (6) 6
Korean (4) 4
Danish (3) 3
Dutch (3) 3
Finnish (3) 3
Ukrainian (3) 3
Croatian (2) 2
Serbian (2) 2
Slovak (2) 2
Bulgarian (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2018, Volume 154, Issue 8, pp. 2237 - 2251.e16
Hepatitis C virus (HCV) infections most often result in chronic outcomes, although the virus constantly produces replication intermediates, in particular... 
Escape | Rab27a | Exosomes | Virology | RESPONSES | PROTEIN | RNA | NS5A | HUMAN LIVER | CELL-CULTURE | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Humans | Hepatitis C, Chronic - virology | Hepatocytes - metabolism | Interferons - immunology | Extracellular Vesicles - metabolism | Host-Pathogen Interactions - immunology | Signal Transduction - immunology | Extracellular Vesicles - immunology | Hepacivirus - physiology | RNA, Viral - isolation & purification | Cell Line | RNA, Double-Stranded - isolation & purification | RNA, Double-Stranded - secretion | Toll-Like Receptor 3 - immunology | Virus Replication - immunology | Hepatocytes - immunology | Immunity, Innate | Toll-Like Receptor 3 - metabolism | Hepatitis C, Chronic - blood | RNA, Viral - secretion | Hepatitis C, Chronic - immunology | RNA, Double-Stranded - immunology | Interferons - metabolism | RNA, Viral - immunology | Primary Cell Culture | Dendritic cells | Hepatitis C virus | Health aspects | Analysis | Index Medicus | Abridged Index Medicus | Hepatocytes/immunology | Toll-Like Receptor 3/metabolism | Toll-Like Receptor 3/immunology | Innate immunity | Extracellular Vesicles/immunology | Hepatitis C, Chronic/blood | Extracellular Vesicles/metabolism | Life Sciences | Host-Pathogen Interactions/immunology | RNA, Double-Stranded/immunology | Immunology | Hepatitis C, Chronic/immunology | RNA, Viral/immunology | RNA, Viral/isolation & purification | Hepatitis C, Chronic/virology | Interferons/metabolism | Hépatology and Gastroenterology | Interferons/immunology | Hepacivirus/physiology | RNA, Viral/metabolism | Virus Replication/immunology | Microbiology and Parasitology | Human health and pathology | Hepatocytes/metabolism | RNA, Double-Stranded/isolation & purification | Signal Transduction/immunology | RNA, Double-Stranded/metabolism
Journal Article
The Journal of biological chemistry, ISSN 1083-351X, 2012, Volume 287, Issue 42, pp. 35631 - 35645
High genetic heterogeneity is an important characteristic of hepatitis C virus (HCV) that contributes to its ability to establish persistent infection. The... 
RESPONSES | LOW-DENSITY | B TYPE-I | NEUTRALIZING ANTIBODIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENVELOPE GLYCOPROTEIN GP70 | E2 GLYCOPROTEIN | RECEPTOR | INFECTION | CELL ENTRY | SEQUENCE EVOLUTION | Protein Structure, Tertiary | CD36 Antigens - genetics | Antibodies, Viral - pharmacology | Humans | Viral Proteins - immunology | CD36 Antigens - immunology | Viral Proteins - genetics | Antibodies, Neutralizing - pharmacology | Hepatitis C - genetics | Viral Proteins - antagonists & inhibitors | Viral Proteins - metabolism | Virus Internalization | Hepatitis C - immunology | Viral Hepatitis Vaccines - immunology | Antibodies, Neutralizing - immunology | Immune Evasion | CD36 Antigens - metabolism | Viral Hepatitis Vaccines - genetics | Antibodies, Viral - immunology | Hepacivirus - physiology | Hepatitis C - prevention & control | Index Medicus | CD36 Antigens/genetics | Viral Proteins/genetics | Hepatitis C/prevention & control | Viral Proteins/antagonists & inhibitors | Antibodies, Viral/immunology | Life Sciences | Viral Hepatitis Vaccines/immunology | Antibodies, Neutralizing/immunology | Viral Proteins/immunology | Hepatitis C/genetics | CD36 Antigens/metabolism | Hepatitis C/immunology | Antibodies, Neutralizing/pharmacology | Viral Hepatitis Vaccines/genetics | CD36 Antigens/immunology | Antibodies, Viral/pharmacology | Hepacivirus/physiology | Virology | Microbiology and Parasitology | Human health and pathology | Infectious diseases | Viral Proteins/metabolism | Virus Entry | Viral Protein | Microbiology | Viral Immunology | Cell Surface Receptor | Hepatitis C Virus | Hypervariable Region 1
Journal Article
PLoS pathogens, ISSN 1553-7374, 2014, Volume 10, Issue 6, p. e1004210
The ability of innate immune cells to sense and respond to impending danger varies by anatomical location. The liver is considered tolerogenic but is still... 
BORRELIA-BURGDORFERI | RESPONSES | INVARIANT T-CELLS | HEPATITIS-B-VIRUS | REPLICATION | VIROLOGY | RECOGNITION | RNA | DISTINCT | KUPFFER CELLS | MICROBIOLOGY | PARASITOLOGY | Leukocytes, Mononuclear - metabolism | Liver - pathology | Hepatitis B - metabolism | Coculture Techniques | Humans | Hepatitis B - virology | Liver - microbiology | Hepacivirus - pathogenicity | Monocytes - immunology | Oligoribonucleotides - pharmacology | Hepatitis C - immunology | Liver - immunology | Liver - drug effects | Pseudomonas aeruginosa - metabolism | T-Lymphocyte Subsets - drug effects | Enterococcus faecalis - immunology | Enterococcus faecalis - pathogenicity | Riboflavin - biosynthesis | Leukocytes, Mononuclear - drug effects | Monocytes - drug effects | Enterococcus faecalis - metabolism | Hepatitis C - virology | Killer Cells, Natural - drug effects | Killer Cells, Natural - metabolism | Toll-Like Receptor 8 - metabolism | Pseudomonas aeruginosa - immunology | T-Lymphocyte Subsets - immunology | Adjuvants, Immunologic - pharmacology | Hepatitis C - metabolism | Hepacivirus - immunology | Hepatitis B virus - pathogenicity | Monocytes - metabolism | Hepatitis B - immunology | Pseudomonas aeruginosa - pathogenicity | Escherichia coli - pathogenicity | Leukocytes, Mononuclear - immunology | Escherichia coli - metabolism | Killer Cells, Natural - immunology | Hepatitis B virus - immunology | Toll-Like Receptor 8 - agonists | Immunity, Innate - drug effects | Interferon-gamma Release Tests | Cells, Cultured | Hepatitis B - pathology | Escherichia coli - immunology | Up-Regulation - drug effects | Leukocytes, Mononuclear - pathology | T-Lymphocyte Subsets - metabolism | Hepatitis C - pathology | Liver diseases | Toll-like receptors | Physiological aspects | Development and progression | Interferon | Drug therapy | Health aspects | Bacterial infections | Liver | Rodents | Immune system
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2012, Volume 109, Issue 16, pp. 6205 - 6210
Hepatitis C virus (HCV) infects ~2% of the world's population. It is estimated that there are more than 500,000 new infections annually in Egypt the country... 
Hepatitis | Antigens | Vaccination | Virions | Antibodies | Viruses | Glycoproteins | Infections | Epitopes | Genotypes | Cross-neutralizing antibody | Virus challenge | Antigenic determinant | Chronic viral infection | Protective determinant | chronic viral infection | DESIGN | STRATEGY | MULTIDISCIPLINARY SCIENCES | E1 GLYCOPROTEIN | virus challenge | antigenic determinant | cross-neutralizing antibody | EPITOPE | CELL-CULTURE SYSTEMS | E2 GLYCOPROTEIN | INFECTION | HUMAN MONOCLONAL-ANTIBODIES | protective determinant | VACCINES | REVEALS | Hepacivirus - immunology | Viral Hepatitis Vaccines - administration & dosage | Humans | Hepacivirus - genetics | Molecular Sequence Data | Immunoblotting | Epitopes, B-Lymphocyte - immunology | Hepatitis C Antibodies - immunology | Peptide Library | Tetraspanin 28 - immunology | Hepatitis C - immunology | Antibodies, Neutralizing - immunology | Antibody Specificity - immunology | HEK293 Cells | Hepatitis C - prevention & control | Antibodies, Monoclonal - immunology | Amino Acid Sequence | Viral Envelope Proteins - genetics | Enzyme-Linked Immunosorbent Assay | Genotype | Viral Hepatitis Vaccines - immunology | Animals | Hepatitis C - virology | Cell Line, Tumor | Viral Envelope Proteins - immunology | Mice | Viral antibodies | Physiological aspects | Hepatitis C virus | Health aspects | Biological Sciences
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2014, Volume 59, Issue 3, pp. 828 - 838
Journal Article
Journal Article
Journal of leukocyte biology, ISSN 0741-5400, 2004, Volume 76, Issue 6, pp. 1180 - 1186
The persistent infection caused by hepatitis C virus (HCV) is presumably explained by a deficient immune response to the infection, but the basis for the... 
NK cells | oxidative burst | CTL | phagocytes | Phagocytes | Oxidative burst | NATURAL-KILLER-CELLS | OXIDATIVE STRESS | ACTIVATION | IMMUNOLOGY | LIVER-DISEASE | IMPAIRMENT | CELL BIOLOGY | INFECTION | HEMATOLOGY | ASSOCIATION | T-CELLS | VIRAL CLEARANCE | Cell Communication - immunology | Cytotoxicity Tests, Immunologic | Reactive Oxygen Species - metabolism | Hepacivirus - immunology | Humans | NADPH Oxidases - metabolism | Oxidative Stress - immunology | Hepacivirus - metabolism | Viral Nonstructural Proteins - pharmacology | Lymphocytes - immunology | T-Lymphocytes - metabolism | Immune Tolerance - immunology | T-Lymphocytes - drug effects | Killer Cells, Natural - immunology | Phagocytes - secretion | Lymphocytes - metabolism | Cell Separation | NADPH Oxidases - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Phagocytes - metabolism | Apoptosis - immunology | Lymphocytes - drug effects | T-Lymphocytes - immunology | Killer Cells, Natural - drug effects | Killer Cells, Natural - metabolism | Reactive Oxygen Species/metabolism | Natural/drug effects/immunology/metabolism | Apoptosis/immunology | Immunologi inom det medicinska området | Phagocytes/metabolism/secretion | Immune Tolerance/immunology | Enzyme Inhibitors/pharmacology | Hepacivirus/immunology/metabolism | T-Lymphocytes/drug effects/immunology/metabolism | Immunologic | Killer Cells | NADPH Oxidase/antagonists & inhibitors/metabolism | Cytotoxicity Tests | Cell Communication/immunology | Oxidative Stress/immunology | Viral Nonstructural Proteins/pharmacology | Immunology in the medical area | Lymphocytes/drug effects/immunology/metabolism
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 1, p. e0210407
Multiplex Serology is a high-throughput technology developed to simultaneously measure specific serum antibodies against multiple pathogens in one reaction... 
HUMAN POLYOMAVIRUSES | HTLV-I | IMMUNOGENICITY | MULTIDISCIPLINARY SCIENCES | I-ASSOCIATED MYELOPATHY | DISEASE | PREVENTION | INFECTION | GLUTATHIONE-S-TRANSFERASE | NATURAL-HISTORY | PROTEINS | Toxoplasma - immunology | HTLV-I Infections - immunology | Antigens, Protozoan - immunology | Toxoplasmosis - immunology | Hepacivirus - immunology | Humans | Hepatitis B - virology | Seroepidemiologic Studies | Hepatitis B - blood | Antibodies, Viral - blood | Serologic Tests - methods | Toxoplasmosis - parasitology | Hepatitis B - immunology | Hepatitis C - immunology | Hepatitis C - blood | Human T-lymphotropic virus 1 - immunology | Hepatitis B virus - immunology | HTLV-I Infections - virology | Antigens, Viral - immunology | High-Throughput Screening Assays | HTLV-I Infections - blood | Hepatitis C - virology | Toxoplasmosis - blood | Antibodies, Viral - immunology | Antigens - immunology | Toxoplasma | Serology | Research | Risk factors | HTLV-I (Virus) | Hepatitis B | Multiplexing | Panels | Leukemia | Antibodies | Cytotoxicity | Viruses | Infections | Assaying | Epidemiology | Proteins | Hepatitis | Liver cancer | Immunology | E coli | Hepatitis B virus | Public health | Pathogens | Antigens | Medical research | Parasitology | Immunoglobulins | Inflammation | Virology | Seroepidemiology | Sensitivity | Lymphomas | Viral infections
Journal Article